US Patent Issued to ANTLERA THERAPEUTICS on March 24 for "Antibodies that bind to LRP6 proteins and methods of use" (Canadian, American Inventors)

ALEXANDRIA, Va., March 24 -- United States Patent no. 12,583,919, issued on March 24, was assigned to ANTLERA THERAPEUTICS INC. (Toronto).

"Antibodies that bind to LRP6 proteins and methods of use" was invented by Sachdev S. Sidhu (Toronto), Guohua Pan (Oakville, Canada), Nish Patel (Scarborough, Canada), Jason Moffat (Toronto), Stephane Angers (Mississauga, Canada), Jarrett Adams (Toronto) and Jagath R. Junutula (Fremont, Calif.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Provided herein are antibodies that specifically bind LRP6 and method of use thereof."

The patent was filed on Aug. 14, 2020, under Application No. 17/634,916.

*For further information, including images, charts and tables, please visi...